Disclosure information not submitted.
Re-analysis of the CSM-PROTECT Multicentre Randomized Controlled Trial Reveals a Global Treatment Benefit of Riluzole in Patients Undergoing Surgery for Degenerative Cervical Myelopathy
Saturday, February 24, 20247:24 AM – 7:26 AM PST
